Chronic ageing diseases like AD favour the formation of a molecular and cellular environment that promotes dysfunction in protein degradation mechanisms and, thereby, accumulation of aggregate-prone proteins such as Aβ and tau. This evidence concerns the gene MAPT and Alzheimer disease.